These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1675602)

  • 81. [Current aspects of the therapy of gastroduodenal peptic ulcer].
    Castro Lde P
    Rev Hosp Clin Fac Med Sao Paulo; 1983; 38(2):90-102. PubMed ID: 6139870
    [No Abstract]   [Full Text] [Related]  

  • 82. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Scheiman JM
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Controversies and trends in ulcer therapy. 2: Prevention of recurrence].
    Berndt H
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):743-8. PubMed ID: 7901948
    [No Abstract]   [Full Text] [Related]  

  • 85. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacologic control of gastric acid secretion in peptic ulcer.
    Konturek SJ
    Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
    [No Abstract]   [Full Text] [Related]  

  • 87. Medical treatment of peptic ulcer disease.
    Andersen BN
    Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Prevention and treatment of gastric mucosal injury in patients taking low-dose aspirin].
    Satoh K; Sugano K
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():450-4. PubMed ID: 22519032
    [No Abstract]   [Full Text] [Related]  

  • 89. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 90. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
    de Bruijne JW; Lamers CB
    Ned Tijdschr Geneeskd; 1989 Apr; 133(13):657-62. PubMed ID: 2566125
    [No Abstract]   [Full Text] [Related]  

  • 93. Acid reduction in peptic ulcer disease. Choosing therapy according to drug interactions, individual response, and cost.
    Parent K
    Postgrad Med; 1994 Nov; 96(6):53-9. PubMed ID: 7971612
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
    Hirschowitz BI
    Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Prevention of ulcer relapse: rationale.
    Dobrilla G
    Hepatogastroenterology; 1988 Dec; 35(6):295-9. PubMed ID: 2905690
    [No Abstract]   [Full Text] [Related]  

  • 97. [Pathophysiologic bases of the pharmacotherapy of peptic ulcer].
    Grigor'ev PIa; Isakov VA; Vasil'eva ZI
    Klin Med (Mosk); 1988 Nov; 66(11):19-27. PubMed ID: 2907071
    [No Abstract]   [Full Text] [Related]  

  • 98. [Acetylsalicylic acid in arterial circulatory disorders. Which dosage in which indication?].
    Ranke C; Creutzig A; Alexander K
    Dtsch Med Wochenschr; 1994 Jun; 119(22):815-21. PubMed ID: 8205945
    [No Abstract]   [Full Text] [Related]  

  • 99. [Ulcer prevention in therapy with low-dose acetylsalicylic acid?].
    Koop H
    Dtsch Med Wochenschr; 1991 Jun; 116(25):996-7. PubMed ID: 1675602
    [No Abstract]   [Full Text] [Related]  

  • 100. Prevention of peptic ulceration in patients receiving NSAIDs.
    Ballinger A
    Br J Hosp Med; 1993 Jun 2-15; 49(11):767-72. PubMed ID: 8101464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.